We Report, You Decide

Odisha Gets Remdesivir In Its COVID-19 Treatment Arsenal, Fabiflu Stock To Reach Soon

Bhubaneswar: Odisha’s fight against Coronavirus was bolstered further as the state received its first batch of Remdesivir drug to be clinically used in case of critically ill COVID-19 patients.

The Union Health Ministry recently approved Remdesivir along with Fabiflu and Dexamethasone as COVID-19 treatments.

As per the Drugs Controller of Odisha, Mamina Patnaik, Remdesivir vials have already reached some of the COVID hospitals in the state. It is a restricted-use drug and meant only for the hospital supplies. The medicine can be used in case of moderate to severely symptomatic patients, Patnaik added.

Similarly, ‘Fabiflu’, another medicine to treat COVID-19-infected patients is going to reach Odisha shortly, informed Patnaik.

At least 1200 strips each containing 34 tablets of Fabiflu are going to reach Odisha soon which will then be distributed to several hospitals in the state to treat patients with mild symptoms of COVID-19. However, the patients have to sign a consent form allowing the hospital to administer the medicine to them, said Patnaik.

Patnaik further said that Odisha currently has a stock of 2 lakh tablets and 2 lakh injections of Dexamethasone, the third approved drug for Coronavirus and it is available in both medicine stores and hospitals.

All the carrying and forwarding (C & F) agents have been advised to keep sufficient stock of all the essential COVID-19 drugs so that it is available on-demand, said Patnaik.

(Edited by Bikram Keshari Jena)

You May Also Read:

Dexamethasone: Health Ministry Adds Steroid In COVID-19 Treatment Protocol

Read Our Next Story